Zhe Nie

Zhe Nie

Schrodinger LLC - - / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4524427
-
person_outline Zhe Nie's MOST POPULAR ARTICLES
1-) Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitorsX Li, S Chu, VA Feher, M Khalili, Z Nie, S Margosiak, V Nikulin, J Levin, ...Journal of medicinal chemistry 46 (26), 5663-5673, 20031772003
2-) Structure-based design, synthesis, and study of potent inhibitors of β-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agentsZ Nie, C Perretta, J Lu, Y Su, S Margosiak, KS Gajiwala, J Cortez, ...Journal of medicinal chemistry 48 (5), 1596-1609, 20051302005
3-) Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer …Z Nie, C Perretta, P Erickson, S Margosiak, J Lu, A Averill, R Almassy, ...Bioorganic & medicinal chemistry letters 18 (2), 619-623, 20081282008
4-) Structure-based design, synthesis, and study of pyrazolo [1, 5-a][1, 3, 5] triazine derivatives as potent inhibitors of protein kinase CK2Z Nie, C Perretta, P Erickson, S Margosiak, R Almassy, J Lu, A Averill, ...Bioorganic & medicinal chemistry letters 17 (15), 4191-4195, 20071252007
5-) TAK-960, a novel, orally available, selective inhibitor of polo-like kinase 1, shows broad-spectrum preclinical antitumor activity in multiple dosing regimensY Hikichi, K Honda, K Hikami, H Miyashita, I Kaieda, S Murai, N Uchiyama, ...Molecular cancer therapeutics 11 (3), 700-709, 2012912012